Stock NTH NATURHOUSE HEALTH, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Naturhouse Health, S.A.

Equities

NTH

ES0105043006

Market Closed - BME
Other stock markets
 11:35:10 2024-05-03 am EDT 		5-day change 1st Jan Change
1.66 EUR 0.00% Intraday chart for Naturhouse Health, S.A. +1.22% +2.47%
Mar. 15 Naturhouse Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Naturhouse Health, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The company's attractive earnings multiples are brought to light by a P/E ratio at 9.76 for the current year.
  • The company has a low valuation given the cash flows generated by its activity.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • Most analysts recommend that the stock should be sold or reduced.

Ratings chart - Surperformance

Sector: Other Specialty Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
NATURHOUSE HEALTH, S.A. Stock Naturhouse Health, S.A.
+2.47% 106M -
TRACTOR SUPPLY COMPANY Stock Tractor Supply Company
+25.66% 28.79B
A-
AVOLTA AG Stock Avolta AG
+7.98% 5.8B
B-
JARIR MARKETING COMPANY Stock Jarir Marketing Company
-12.71% 4.35B
C
JUMBO S.A. Stock Jumbo S.A.
+17.36% 4.29B
C+
GRUPO GIGANTE, S. A. B. DE C. V. Stock Grupo Gigante, S. A. B. de C. V.
+4.23% 1.88B -
B-
UPBOUND GROUP, INC. Stock Upbound Group, Inc.
-9.42% 1.66B
C+
WINMARK CORPORATION Stock Winmark Corporation
-12.75% 1.26B -
C
SALLY BEAUTY HOLDINGS, INC. Stock Sally Beauty Holdings, Inc.
-18.83% 1.15B
B-
LESLIE'S, INC. Stock Leslie's, Inc.
-31.84% 804M
D+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. NTH Stock
  4. Ratings Naturhouse Health, S.A.